PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19800413-4 2009 The orexigenic activity of C5a was blocked by co-administration of a DP(1) receptor antagonist, BWA868C. BW A868C 96-103 hemolytic complement Mus musculus 27-30 22503964-4 2012 C5a-induced anxiolytic-like activity was inhibited by indomethacin, a cyclooxygenase inhibitor, or BWA868C, an antagonist of DP(1) receptor for PGD(2), respectively. BW A868C 99-106 hemolytic complement Mus musculus 0-3